ORKA

Oruka Therapeutics, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Venrock Healthcare Capital Partners III, L.P.10 Percent Owner
$1.0M88.8k shares
BuyFeb 14, 2025
$11.44
--
Goncalves JoanaChief Medical Officer
$97k3.1k shares
SellDec 19, 2025
$31.58
--
Goncalves JoanaChief Medical Officer
$46k1.5k shares
SellDec 19, 2025
$30.70
--
Goncalves JoanaChief Medical Officer
$53k1.8k shares
SellDec 19, 2025
$29.62
--
Goncalves JoanaChief Medical Officer
$18k641 shares
SellDec 19, 2025
$28.53
--
Sandler Laura LeeChief Operating Officer
$33k1.1k shares
SellJan 2, 2026
$29.75
--

News

zacks.comOruka Therapeutics, Inc. (ORKA) Upgraded to Buy: What Does It Mean for the Stock?zacks.comJun 12zacks.comWall Street Analysts Believe Oruka Therapeutics, Inc. (ORKA) Could Rally 111.13%: Here's is How to Tradezacks.comJun 10fool.comAn Oruka Therapeutics (ORKA) Insider Sold 105,000 Shares Worth $6.2 Millionfool.comMay 31globenewswire.comOruka Therapeutics to Present at the 2026 Jefferies Global Healthcare Conferenceglobenewswire.comMay 28globenewswire.comOruka Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updateglobenewswire.comMay 13